Literature DB >> 30256551

A 6-Month, Prospective, Randomized Controlled Trial of Customized Adherence Enhancement Versus Bipolar-Specific Educational Control in Poorly Adherent Individuals With Bipolar Disorder.

Martha Sajatovic1,2, Curtis Tatsuoka3, Kristin A Cassidy4, Peter J Klein4, Edna Fuentes-Casiano4, Jamie Cage5, Michelle E Aebi4, Luis F Ramirez4, Carol Blixen4, Adam T Perzynski6, Mark S Bauer7, Steven A Safren8, Jennifer B Levin2.   

Abstract

OBJECTIVE: Nonadherence in bipolar disorder (BD) ranges from 20% to 60%. Customized adherence enhancement (CAE) is a brief, BD-specific approach that targets individual adherence barriers. This prospective, 6-month, randomized controlled trial conducted from October 2012 to July 2017 compared CAE versus a rigorous BD-specific educational program (EDU) on adherence, symptoms, and functional outcomes in poorly adherent individuals.
METHODS: One hundred eighty-four participants with DSM-IV BD were randomized to CAE (n = 92) or EDU (n = 92). Primary outcome was adherence change measured by the Tablets Routine Questionnaire (TRQ) and BD symptoms measured by the Brief Psychiatric Rating Scale. Other outcomes were scores on the Global Assessment of Functioning, Montgomery-Asberg Depression Rating Scale, Young Mania Rating Scale, and Clinical Global Impressions Scale. Assessments were conducted at screening, baseline, 10 weeks, 14 weeks, and 6 months.
RESULTS: The sample mean (SD) age was 47.40 (10.46) years; 68.5% were female, and 63.0% were African American. At screening, individuals missed a mean (SD) of 55.15% (28.22%) of prescribed BD drugs within the past week and 48.01% (28.46%) in the past month. Study attrition was < 20%. At 6 months, individuals in CAE had significantly improved past-week (P = .001) and past-month (P = .048) TRQ scores versus those in EDU. Past-week TRQ score improvement remained significant after adjustment for multiple comparisons. There were no treatment arm differences in BPRS scores or other symptoms, possibly related to low symptom baseline values. Baseline-to-6-month comparison showed significantly higher GAF scores (P = .036) for CAE versus EDU. Although both groups used more mental health services at 6 months compared to baseline, increase for CAE was significantly less than that for EDU (P = .046).
CONCLUSIONS: Whereas both CAE and EDU were associated with improved outcomes, CAE had additional positive effects on adherence, functioning, and mental health resource use compared to EDU. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00183495. © Copyright 2018 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30256551      PMCID: PMC6205506          DOI: 10.4088/JCP.17m12036

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  33 in total

1.  Customized adherence enhancement for individuals with bipolar disorder receiving antipsychotic therapy.

Authors:  Martha Sajatovic; Jennifer Levin; Curtis Tatsuoka; Weronika Micula-Gondek; Tiffany D Williams; Christopher S Bialko; Kristin A Cassidy
Journal:  Psychiatr Serv       Date:  2012-02-01       Impact factor: 3.084

2.  Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs.

Authors:  Mark S Bauer; Linda McBride; William O Williford; Henry Glick; Bruce Kinosian; Lori Altshuler; Thomas Beresford; Amy M Kilbourne; Martha Sajatovic
Journal:  Psychiatr Serv       Date:  2006-07       Impact factor: 3.084

3.  Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

Authors:  M K Spearing; R M Post; G S Leverich; D Brandt; W Nolen
Journal:  Psychiatry Res       Date:  1997-12-05       Impact factor: 3.222

4.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

5.  Use of a self-report-generated Charlson Comorbidity Index for predicting mortality.

Authors:  Saima Chaudhry; Lei Jin; David Meltzer
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

6.  A 2-year follow-up study of discharged psychiatric patients with bipolar disorder.

Authors:  Chunyang Li; Chao Chen; Bin Qiu; Guang Yang
Journal:  Psychiatry Res       Date:  2014-04-18       Impact factor: 3.222

7.  Clinical factors associated with treatment noncompliance in euthymic bipolar patients.

Authors:  F Colom; E Vieta; A Martínez-Arán; M Reinares; A Benabarre; C Gastó
Journal:  J Clin Psychiatry       Date:  2000-08       Impact factor: 4.384

8.  Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder.

Authors:  Martha Sajatovic; Jennifer Levin; Curtis Tatsuoka; Weronika Micula-Gondek; Edna Fuentes-Casiano; Christopher S Bialko; Kristin A Cassidy
Journal:  Bipolar Disord       Date:  2012-05       Impact factor: 6.744

9.  Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic.

Authors:  Martha Sajatovic; Rosalinda V Ignacio; Jane A West; Kristin A Cassidy; Roknedin Safavi; Amy M Kilbourne; Frederic C Blow
Journal:  Compr Psychiatry       Date:  2008-08-23       Impact factor: 3.735

10.  Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder.

Authors:  Martha Sajatovic; Jennifer B Levin; Johnny Sams; Kristin A Cassidy; Kouri Akagi; Michelle E Aebi; Luis F Ramirez; Steven A Safren; Curtis Tatsuoka
Journal:  Bipolar Disord       Date:  2015-09       Impact factor: 6.744

View more
  6 in total

1.  Understanding Aging in Bipolar Disorder by Integrating Archival Clinical Research Datasets.

Authors:  Lisa T Eyler; Michelle E Aebi; Rebecca E Daly; Kristen Hansen; Curtis Tatsuoka; Robert C Young; Martha Sajatovic
Journal:  Am J Geriatr Psychiatry       Date:  2019-04-18       Impact factor: 4.105

2.  The Relationship Between Medication Attitudes and Medication Adherence Behavior in Adults With Bipolar Disorder.

Authors:  Jennifer B Levin; Michelle E Aebi; Molly Howland; Marina Barboza; Logan Eskew; Curtis Tatsuoka; Kristin A Cassidy; Martha Sajatovic
Journal:  J Nerv Ment Dis       Date:  2020-02       Impact factor: 1.899

3.  A customized adherence enhancement program for adolescents and young adults with suboptimal adherence and bipolar disorder: Trial design and methodological report.

Authors:  Molly McVoy; Melissa Delbello; Jennifer Levin; Avani C Modi; Larry F Forthun; Farren Briggs; Deionte Appling; Michaela Broadnax; Carla Conroy; Raechel Cooley; George Eapen; Martha Sajatovic
Journal:  Contemp Clin Trials       Date:  2022-03-09       Impact factor: 2.261

4.  Medication Self-Management in Hospitalised Patients with Schizophrenia or Bipolar Disorder: The Perceptions of Patients and Healthcare Providers.

Authors:  Elke Loots; Josée Leys; Shara Proost; Manuel Morrens; Inge Glazemakers; Tinne Dilles; Bart Van Rompaey
Journal:  Int J Environ Res Public Health       Date:  2022-04-15       Impact factor: 4.614

5.  A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project.

Authors:  Jennifer B Levin; Farren Briggs; Carol Blixen; Mark Bauer; Douglas Einstadter; Jeffrey M Albert; Celeste Weise; Nicole Woods; Edna Fuentes-Casiano; Kristin A Cassidy; Julie Rentsch; Kaylee Sarna; Martha Sajatovic
Journal:  Trials       Date:  2022-08-04       Impact factor: 2.728

6.  Patient Factors Influencing Outpatient Retention in Patients with Affective and Anxiety Disorders: A Retrospective Study.

Authors:  Seyeon Chang; Young Sup Woo; Sheng-Min Wang; Hyun Kook Lim; Won-Myong Bahk
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-08-31       Impact factor: 2.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.